GLP-1 receptor agonists in medicine act like the natural hormone but stay active in the body for a longer time
Whether that vision is fully realized will depend on pricing, insurance coverage, and regulatory outcomes
23431 (May 1, 2026), the FDA proposed to restrict large-scale 503B compounding of these medications, with a public comment period open through June 29, 2026
The best option depends on your BMI, medical history, side effects, preferences and prescriber assessment
This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License
Your doctor must evaluate your overall health, medication interactions, and personal or family history of thyroid cancer before initiating therapy